Apex Healthcare Berhad (KLSE: AHEALTH)
Malaysia
· Delayed Price · Currency is MYR
2.430
-0.030 (-1.22%)
At close: Dec 20, 2024
Apex Healthcare Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 964.28 | 936.17 | 877.74 | 770.76 | 698.73 | 688.79 | Upgrade
|
Revenue Growth (YoY) | 5.19% | 6.66% | 13.88% | 10.31% | 1.44% | 5.54% | Upgrade
|
Cost of Revenue | 743.59 | 721.34 | 680.15 | 609.78 | 550.51 | 534.11 | Upgrade
|
Gross Profit | 220.68 | 214.83 | 197.59 | 160.97 | 148.22 | 154.68 | Upgrade
|
Selling, General & Admin | 127.04 | 123.86 | 112 | 98.08 | 93.29 | 99.06 | Upgrade
|
Other Operating Expenses | 11.18 | 12.2 | -2.14 | -2.77 | -4.75 | -1.34 | Upgrade
|
Operating Expenses | 138.21 | 136.06 | 109.87 | 95.31 | 88.54 | 97.72 | Upgrade
|
Operating Income | 82.47 | 78.77 | 87.73 | 65.66 | 59.67 | 56.96 | Upgrade
|
Interest Expense | -1.02 | -0.56 | -0.76 | -0.86 | -1.15 | -1.58 | Upgrade
|
Interest & Investment Income | 6.86 | 6.86 | 1.62 | 1.82 | 1.79 | 2.15 | Upgrade
|
Earnings From Equity Investments | 14.1 | 336.4 | 29.57 | 7.1 | 8.66 | 7.3 | Upgrade
|
Currency Exchange Gain (Loss) | 1.55 | 1.55 | 1.51 | 1.25 | 0.99 | 1.1 | Upgrade
|
EBT Excluding Unusual Items | 107.44 | 423.02 | 119.66 | 74.96 | 69.97 | 65.92 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.28 | 0.28 | 0.69 | 0.18 | 0.18 | 0.37 | Upgrade
|
Pretax Income | 107.73 | 423.31 | 120.36 | 75.41 | 70.17 | 66.33 | Upgrade
|
Income Tax Expense | 24.59 | 25.32 | 19.38 | 15.98 | 14.16 | 13.56 | Upgrade
|
Earnings From Continuing Operations | 83.14 | 397.99 | 100.97 | 59.44 | 56.01 | 52.77 | Upgrade
|
Minority Interest in Earnings | - | - | 0 | -0.02 | 0.01 | -0.02 | Upgrade
|
Net Income | 83.14 | 397.99 | 100.97 | 59.42 | 56.02 | 52.75 | Upgrade
|
Net Income to Common | 83.14 | 397.99 | 100.97 | 59.42 | 56.02 | 52.75 | Upgrade
|
Net Income Growth | -79.86% | 294.15% | 69.94% | 6.06% | 6.20% | -9.95% | Upgrade
|
Shares Outstanding (Basic) | 715 | 714 | 711 | 710 | 710 | 707 | Upgrade
|
Shares Outstanding (Diluted) | 715 | 715 | 714 | 711 | 712 | 710 | Upgrade
|
Shares Change (YoY) | 0.02% | 0.16% | 0.33% | -0.14% | 0.34% | 0.39% | Upgrade
|
EPS (Basic) | 0.12 | 0.56 | 0.14 | 0.08 | 0.08 | 0.07 | Upgrade
|
EPS (Diluted) | 0.12 | 0.56 | 0.14 | 0.08 | 0.08 | 0.07 | Upgrade
|
EPS Growth | -79.87% | 293.50% | 69.46% | 6.10% | 5.92% | -10.37% | Upgrade
|
Free Cash Flow | -33.82 | 39.26 | 41.76 | 50.85 | 69.66 | 53.83 | Upgrade
|
Free Cash Flow Per Share | -0.05 | 0.05 | 0.06 | 0.07 | 0.10 | 0.08 | Upgrade
|
Dividend Per Share | 0.085 | 0.050 | 0.043 | 0.037 | 0.030 | 0.025 | Upgrade
|
Dividend Growth | 75.98% | 15.47% | 17.98% | 22.33% | 21.46% | 9.78% | Upgrade
|
Gross Margin | 22.89% | 22.95% | 22.51% | 20.88% | 21.21% | 22.46% | Upgrade
|
Operating Margin | 8.55% | 8.41% | 9.99% | 8.52% | 8.54% | 8.27% | Upgrade
|
Profit Margin | 8.62% | 42.51% | 11.50% | 7.71% | 8.02% | 7.66% | Upgrade
|
Free Cash Flow Margin | -3.51% | 4.19% | 4.76% | 6.60% | 9.97% | 7.82% | Upgrade
|
EBITDA | 100.99 | 95.47 | 103.03 | 80.8 | 74.88 | 71.56 | Upgrade
|
EBITDA Margin | 10.47% | 10.20% | 11.74% | 10.48% | 10.72% | 10.39% | Upgrade
|
D&A For EBITDA | 18.52 | 16.69 | 15.31 | 15.14 | 15.21 | 14.6 | Upgrade
|
EBIT | 82.47 | 78.77 | 87.73 | 65.66 | 59.67 | 56.96 | Upgrade
|
EBIT Margin | 8.55% | 8.41% | 9.99% | 8.52% | 8.54% | 8.27% | Upgrade
|
Effective Tax Rate | 22.82% | 5.98% | 16.11% | 21.18% | 20.18% | 20.45% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.